Welcure Drugs Pharmaceuticals Ltd vs Wol 3d India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0.18 as of 23 Oct 15:30 . The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of WOL 3D India Ltd changed from 12.4 on March 2025 to 11 on March 2026 . This represents a CAGR of -5.81% over 2 years The Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of WOL 3D India Ltd changed from ₹ 69.42 crore on March 2025 to ₹ 73.1 crore on March 2026 . This represents a CAGR of 2.62% over 2 years The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The revenue of WOL 3D India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The ebitda of WOL 3D India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The net profit of WOL 3D India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of WOL 3D India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

About WOL 3D India Ltd

WOL 3D India Limited was originally incorporated as a Private Company as 'Parekh Polyster Private Limited' on November 01, 1988.
The name of the Company was changed from 'Parekh Polyster Private Limited' to 'Wol 3D India Private Limited' on June 20, 2018.
Accordingly, the status of Company was changed into Public Limited Company to 'WOL 3D India Limited vide Fresh Certificate of Incorporation dated January 02, 2023, issued by Registrar of Companies, Mumbai. The Company is engaged in the business of providing 3D Printing solutions enabling easier prototyping finding its application in various sectors like manufacturing, education, engineering, architecture, interior designing, fashion designing, product designing, medical, dental etc.
The Company product portfolio comprise of Desktop 3D Printer, Industrial 3D Printer, Resin 3D Printer, DIY 3D Printer, Multi Color 3D Printer, etc.

FAQs for the comparison of Welcure Drugs & Pharmaceuticals Ltd and WOL 3D India Ltd

Which company has a larger market capitalization, Welcure Drugs & Pharmaceuticals Ltd or WOL 3D India Ltd?

Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr while Market cap of WOL 3D India Ltd is 81 Cr

What are the key factors driving the stock performance of Welcure Drugs & Pharmaceuticals Ltd and WOL 3D India Ltd?

The stock performance of Welcure Drugs & Pharmaceuticals Ltd and WOL 3D India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Welcure Drugs & Pharmaceuticals Ltd and WOL 3D India Ltd?

As of October 24, 2026, the Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18. On the other hand, WOL 3D India Ltd stock price is INR ₹126.15.

How do dividend payouts of Welcure Drugs & Pharmaceuticals Ltd and WOL 3D India Ltd compare?

To compare the dividend payouts of Welcure Drugs & Pharmaceuticals Ltd and WOL 3D India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.